SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Viad Corp (NYSE: VVI), a leading global provider of extraordinary experiences, including attractions, hospitality, exhibition management services, and experiential marketing, today reported results for the 2024 first quarter. Steve Moster, Viad’s President and Chief Executive Officer, commented, “We delivered solid first quarter results that were in line with our expectations. Pursuit's 14% revenue growth during the seasonally slower quarter was driven by strong attractions performance, including an impressive launch of our new FlyOver Chicago attraction....
Altisource Announces First Quarter 2024 Financial Results LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the first quarter 2024. “I am very pleased with our first quarter performance. We generated $4.6 million of Adjusted EBITDA(1), marking our best quarterly performance since the third quarter of 2020, on $36.9 million of service revenue. We are winning meaningful new business and ramping ...
Altisource Portfolio Solutions S.A. Schedules First Quarter 2024 Conference Call LUXEMBOURG, April 18, 2024 (GLOBE NEWSWIRE) -- On Thursday, April 25, 2024, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the first quarter 2024. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its first quarter 2024 results. A link to the live audio webcast will be available on Altisource’s website in the Investor R...
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- (NYSE: ), a leading provider of extraordinary experiences, including attractions, hospitality, exhibition management services, and experiential marketing, announced today that President and Chief Executive Officer Steve Moster and Chief Financial Officer Ellen Ingersoll will host a teleconference with investors and analysts to review first quarter 2024 results. They will be joined by Pursuit President David Barry. Our call will be held on Thursday, May 2, 2024, at 5 p.m. (Eastern Time). We will issue a press release outlining our financial results and outl...
Bassett’s 1QFY24 operating results disappointing, but not surprising. In its 2023 Annual Report, Bassett CEO Rob Spilman’s opening line was, “The other side of the COVID sales boom has proven to a rough ride for the home furnishings sector.” It remains challenging. Several untimely winter storms hit on important selling days, including the MLK holiday sale period. Moreover, comments from several other reporting companies noting the recent challenges underscore the recent malaise. Investors seem ...
Bassett Announces Fiscal First Quarter Results BASSETT, Va., April 03, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today its results of operations for its first quarter ended March 2, 2024. Fiscal 2024 First Quarter Highlights (Dollars in millions) Sales Operating Income (Loss) 1st Qtr Dollar% 1st Qtr% of 1st Qtr% of 2024 2023 ChangeChange 2024 Sales 2023 SalesConsolidated (1) $86.6 $107.7 $(21.1)-19.6% $(2.4)-2.8% $2.7 2.5% Wholesale $54.7 $69.9 $(15.2)-21.7% $6.8 12.4% $9.0 12.9% Retail $53.8 $65.0 $(11.2)-17...
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference WEST CHESTER, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica’s President & Chief Executive Officer, will present at the upcoming 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from April 8-11, 2024. Event details:Date: Tuesday, April 9, 2024Time: 2:15 pm ET...
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA NCE status provides a minimum of five years of regulatory exclusivity The Company’s U.S. patents and pending patent applications related to YCANTH™ are projected to expire between 2034 and 2041, excluding any patent term adjustment or patent term extension WEST CHESTER, Pa., March 26, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring m...
Moody's Ratings has completed a periodic review of the ratings of Viad Corp and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 12 March 2024 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant...
Bassett Announces Regular Quarterly Dividend BASSETT, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today that its Board of Directors has declared a regular quarterly dividend of $0.18 per share of common stock, payable on May 31, 2024, to shareholders of record at the close of business on May 17, 2024. About Bassett Furniture Industries, Inc.Bassett Furniture Industries, Inc. (NASDAQ:BSET), is a leading manufacturer and marketer of high quality home furnishings. With 89 company- and licensee-owned stores at the time of this release, ...
Altisource Announces Fourth Quarter and Full Year 2023 Financial Results LUXEMBOURG, March 07, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the fourth quarter and full year 2023. “I am pleased with our performance in 2023 as we continue to strengthen our financial position and win new business which has not fully ramped. In the face of serious market headwinds for both Business Segments, Service revenue ...
Lenders One Brings Together Its Members and Providers to Help Members Increase Profitability During Challenging Markets LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- Lenders One® Cooperative (“L1” or “Lenders One”), a national alliance of independent mortgage bankers, banks and credit unions, managed by a subsidiary of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), welcomes members and providers to the L1 Summit, its annual conference at L.A. LIVE in Los Angeles, CA. During the three-day event, members will celebrate the strength of Lenders One and a...
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results – Reports YCANTH™ revenue of $1.9M for fourth quarter and $4.7M for full year 2023 – – Over 200 million lives now covered on commercial insurance and managed Medicaid plans – – Conference Call Scheduled for Today at 8:30 am ET – WEST CHESTER, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced financial results for the fourth quarter and...
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- (NYSE: ) announced today that President and Chief Executive Officer Steve Moster and Chief Financial Officer Ellen Ingersoll will participate in the following upcoming investor conferences: March 13: BofA Securities 2024 Consumer & Retail Conference – 1 Hotel South Beach in Miami Beach, Florida March 15: J.P. Morgan Gaming, Lodging, Restaurant & Leisure Management Access Forum – Four Seasons Hotel in Las Vegas, Nevada An updated investor presentation will be posted on our website at on Wednesday, March 13th by 8 a.m. Eastern Time. About Viad ...
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference WEST CHESTER, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that they will participate in a fireside chat at the TD Cowen 44th Annual Healthcare Conference, which will be held in Boston, Massachusetts. Event details:Date: Tuesday, March 5, 2024Time: 10:30am ETLocation: Boston, MA Participants may acces...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.